To Bekonaza

Беконазе Drug photo

The description is actual on 09.06.2016

  • Latin name: Beconase
  • ATH code: R01AD01
  • Active ingredient: Beclomethasone
  • Producer: Glakso Village of Welkom. And. (Spain)


1 dose of spray contains 50 mkg of active ingredient beclomethasone.

Release form

To Bekonaza is issued in the form of the dosed nasal spray.

Pharmacological action


Pharmacodynamics and pharmacokinetics

The main, active ingredient – beclomethasone. To Bekonaza has antiallergenic, antiinflammatory effects.

Actively active ingredient of drug slows down process of release of mediators of an inflammation, strengthens production of inhibitor of a phospholipase of A2 of an anneksin (lipokortin) that reduces production of arachidonic acid and its metabolites (leukotrienes and prostaglandins).

Beclomethasone oppresses process of synthesizing of prostaglandins, cyclic endoperoxides and the factor activating thrombocytes.

To Bekonaza oppresses production of substances of a chemotaxis, reduces the speed of development of immediate allergic reaction, improves mukotsiliarny transport.

At effect of beclomethasone the number of mast cells in mucous membranes of adnexal bosoms, a nasal cavity decreases, puffiness, slime secretion decreases, it is braked development of macrophages, regional accumulation of neutrophils decreases.

These mechanisms take active part in forming of the allergic answer. Beklametazon raises number of active beta adrenoceptors.

At intranasal introduction has no resorptive effect.

At topical administration in the recommended doses does not lead to forming of side effects which often arise when using glucocorticosteroids.

Therapeutic the significant effect forms gradually.

Indications to use

To Bekonaza appoint at inflammatory processes in a nasal cavity of noninfectious genesis, at a recurrent current a nose polypose, at allergic rhinitis (year-round, seasonal options of a current).


To Bekonaza it is contraindicated at intolerance of beclomethasone.

At glaucoma, an amebiasis, a hypothyroidism, pathology of renal system, a myocardial infarction in the anamnesis, herpes of eyes, system infections (a bacterial, fungal origin), a nose partition ulceration, at a pulmonary tuberculosis, recently postponed injuries and operations, at chest feeding, at pregnancy appoint to a nose with care.

Side effects

Use to Bekonaza can be followed by headaches, nasal bleedings, a rhinorrhea. The atrophy and an ulceration mucous a nose, a conjunctiva hyperemia, perforation of a partition of a nose, a mialgiya, a food faddism, cough, the increased drowsiness, increase of intraocular pressure is in rare instances noted.

Spray to Bekonaza, application instruction (Way and dosage)

To Bekonaza apply intranazalno: on 2 inhalations in each nasal course twice a day, or 100 mkg on 3-4 receptions. A day no more than 1 mg.


At overdose signs of oppression of gipotalamo-pituitary and adrenal functions are registered.

The antidote does not exist.

Terms of sale

The recipe is not required.

Storage conditions

In the place, dark, unavailable to children, at a temperature no more than 30 degrees Celsius.

Period of validity

No more than two years.

Special instructions

It is important to watch that medicine did not contact to eyes.

At chest feeding and incubation of pregnancy to Bekonaza appoint in exceptional cases, estimating potential advantage and risk for a fruit or the child.

There are no reliable data about safety use of beclomethasone for the feeding and pregnant women.

Analogs Bekonaza

Analogs in Ukraine are Beklonazal, Nasobek.

About Bekonaz

Drug is effective according to indications to use.


  • Bekonazeglaxo Wellcome Operations (Great Britain)
  • To Bekonaza aerosol 50mkg/dose 180 dozglakso SK (Great Britain)


  • To Bekonaza aer. 50mkg/dose 180 doses
Section: Hormonal From an allergy
in more detail

Education: Graduated from the Bashkir state medical university majoring in "Medical business". In 2011 gained the diploma and the certificate in Therapy. In 2012 received 2 certificate and the diploma in "Functional diagnosis" and "Cardiology". In 2013 completed courses on "Topical issues of otorhinolaryngology in therapy". In 2014 completed advanced training courses in "A clinical echocardiography" and courses in "Medical rehabilitation".

Experience: From 2011 to 2014 the Policlinic No. 33 Ufa worked as the therapist and the cardiologist in MBUZ. Since 2014 the Policlinic No. 33 Ufa works as the cardiologist and the doctor of functional diagnosis in MBUZ.

PAY ATTENTION! Information on drugs on the website is help generalizing, collected from public sources and can form the basis for making decision on use of medicines it is not aware of treatment. Before medicine use to Bekonaza surely consult with the attending physician.